Watanabe S, Iwai T, Matsushita R, Nakanishi T, Kuzhiumparambil U, Fu S
Forensic Toxicol. 2022; 40(2):278-288.
PMID: 36454404
DOI: 10.1007/s11419-022-00612-2.
Musial J, Powierska-Czarny J, Czarny J, Raczkowski M, Galant N, Buszewski B
Arch Toxicol. 2022; 96(11):2927-2933.
PMID: 36008489
PMC: 9525419.
DOI: 10.1007/s00204-022-03343-w.
Simao A, Antunes M, Cabral E, Oliveira P, Rosendo L, Brinca A
Int J Environ Res Public Health. 2022; 19(8).
PMID: 35457736
PMC: 9028227.
DOI: 10.3390/ijerph19084869.
Fiorentini A, Cantu F, Crisanti C, Cereda G, Oldani L, Brambilla P
Front Psychiatry. 2022; 12:694863.
PMID: 35002789
PMC: 8732862.
DOI: 10.3389/fpsyt.2021.694863.
Sezer Y, Jannuzzi A, Huestis M, Alpertunga B
Toxicol Res (Camb). 2021; 9(6):734-740.
PMID: 33447358
PMC: 7786167.
DOI: 10.1093/toxres/tfaa078.
The short-acting synthetic cannabinoid AB-FUBINACA induces physical dependence in mice.
Trexler K, Vanegas S, Poklis J, Kinsey S
Drug Alcohol Depend. 2020; 214:108179.
PMID: 32688070
PMC: 7461724.
DOI: 10.1016/j.drugalcdep.2020.108179.
Phenotype-Based Screening of Synthetic Cannabinoids in a Dravet Syndrome Zebrafish Model.
Griffin A, Anvar M, Hamling K, Baraban S
Front Pharmacol. 2020; 11:464.
PMID: 32390835
PMC: 7193054.
DOI: 10.3389/fphar.2020.00464.
The Bridge Between Classical and "Synthetic"/Chemical Psychoses: Towards a Clinical, Psychopathological, and Therapeutic Perspective.
Orsolini L, Chiappini S, Papanti D, de Berardis D, Corkery J, Schifano F
Front Psychiatry. 2019; 10:851.
PMID: 31849723
PMC: 6896660.
DOI: 10.3389/fpsyt.2019.00851.
Neurocognition and Subjective Experience Following Acute Doses of the Synthetic Cannabinoid JWH-018: Responders Versus Nonresponders.
Theunissen E, Hutten N, Mason N, Toennes S, Kuypers K, Ramaekers J
Cannabis Cannabinoid Res. 2019; 4(1):51-61.
PMID: 31363493
PMC: 6661919.
DOI: 10.1089/can.2018.0047.
Toxic by design? Formation of thermal degradants and cyanide from carboxamide-type synthetic cannabinoids CUMYL-PICA, 5F-CUMYL-PICA, AMB-FUBINACA, MDMB-FUBINACA, NNEI, and MN-18 during exposure to high temperatures.
Kevin R, Kovach A, Lefever T, Gamage T, Wiley J, McGregor I
Forensic Toxicol. 2019; 37(1):17-26.
PMID: 30705707
PMC: 6349387.
DOI: 10.1007/s11419-018-0430-0.
Convulsant Effects of Abused Synthetic Cannabinoids JWH-018 and 5F-AB-PINACA Are Mediated by Agonist Actions at CB1 Receptors in Mice.
Wilson C, Tai S, Ewing L, Crane J, Lockhart T, Fujiwara R
J Pharmacol Exp Ther. 2018; 368(2):146-156.
PMID: 30420360
PMC: 6323622.
DOI: 10.1124/jpet.118.251157.
Neurocognition and subjective experience following acute doses of the synthetic cannabinoid JWH-018: a phase 1, placebo-controlled, pilot study.
Theunissen E, Hutten N, Mason N, Toennes S, Kuypers K, de Sousa Fernandes Perna E
Br J Pharmacol. 2017; 175(1):18-28.
PMID: 29164599
PMC: 5740243.
DOI: 10.1111/bph.14066.
In vitro and in vivo pharmacokinetics and metabolism of synthetic cannabinoids CUMYL-PICA and 5F-CUMYL-PICA.
Kevin R, Lefever T, Snyder R, Patel P, Fennell T, Wiley J
Forensic Toxicol. 2017; 35(2):333-347.
PMID: 28824730
PMC: 5519669.
DOI: 10.1007/s11419-017-0361-1.
Metabolic Profile of Synthetic Cannabinoids 5F-PB-22, PB-22, XLR-11 and UR-144 by Cunninghamella elegans.
Watanabe S, Kuzhiumparambil U, Nguyen M, Cameron J, Fu S
AAPS J. 2017; 19(4):1148-1162.
PMID: 28455676
DOI: 10.1208/s12248-017-0078-4.
Pharmacological and Toxicological Effects of Synthetic Cannabinoids and Their Metabolites.
Tai S, Fantegrossi W
Curr Top Behav Neurosci. 2016; 32:249-262.
PMID: 28012093
PMC: 5392241.
DOI: 10.1007/7854_2016_60.
Evaluation of first generation synthetic cannabinoids on binding at non-cannabinoid receptors and in a battery of in vivo assays in mice.
Wiley J, Lefever T, Marusich J, Grabenauer M, Moore K, Huffman J
Neuropharmacology. 2016; 110(Pt A):143-153.
PMID: 27449567
PMC: 5028280.
DOI: 10.1016/j.neuropharm.2016.07.016.
Analysis of Parent Synthetic Cannabinoids in Blood and Urinary Metabolites by Liquid Chromatography Tandem Mass Spectrometry.
Knittel J, Holler J, Chmiel J, Vorce S, Magluilo Jr J, Levine B
J Anal Toxicol. 2016; 40(3):173-86.
PMID: 26792810
PMC: 4885915.
DOI: 10.1093/jat/bkv137.
Cluster of Acute Toxicity from Ingestion of Synthetic Cannabinoid-Laced Brownies.
Obafemi A, Kleinschmidt K, Goto C, Fout D
J Med Toxicol. 2015; 11(4):426-9.
PMID: 25967137
PMC: 4675604.
DOI: 10.1007/s13181-015-0482-z.
Validation of an ELISA Synthetic Cannabinoids Urine Assay.
Barnes A, Spinelli E, Young S, Martin T, Kleete K, Huestis M
Ther Drug Monit. 2015; 37(5):661-9.
PMID: 25706046
PMC: 4544679.
DOI: 10.1097/FTD.0000000000000201.
Spice/K2 synthetic marijuana-induced toxic hepatitis treated with N-acetylcysteine.
Sheikh I, Luksic M, Ferstenberg R, Culpepper-Morgan J
Am J Case Rep. 2014; 15:584-8.
PMID: 25548903
PMC: 4282190.
DOI: 10.12659/AJCR.891399.